Inquiry into approval processes for new drugs and novel medical technologies in Australia

House of Representatives inquiry into approval processes for new drugs and novel medical technologies in Australia

The George Institute for Global Health is pleased to make a submission to the House of Representatives Standing Committee on Health, Aged Care and Sport in relation to their inquiry into approval processes for new drugs and novel medical  technologies in Australia.

The George Institute has developed novel medical technologies including Join Us: national research register, The Affordable Dialysis System, Polypill, the FoodSwitch App, and SMARThealth.

We believe there are several incentives the Australian Government can offer to research, development and commercialisation in relation to new drugs and novel medical technologies, particularly for non-communicable diseases. We recommend several measures to make Australia a more attractive location for clinical trials, and make the approval process for new drugs and novel medical technologies more efficient, without compromising safety, quality, efficacy or cost-effectiveness.